Dr. Adam J. Schwarz, Pediatric Critical Care

With a passion for research in pediatric critical care medicine, Dr. Schwarz supervises the clinical research program within the division of pediatric critical care, overseeing many different national multi-center clinical research studies in pediatric critical care, including studies of therapeutic hypothermia after pediatric cardiac arrest (THAPCA), implementation of a sedation protocol for children with respiratory failure on mechanical ventilator support (RESTORE), inflammatory and genetic biomarkers of septic shock, biomarkers of acute lung injury (BALI), pharmacokinetics of sedation medications (PISA), neuro-developmental consequences of critical pertussis, inflammatory responses to critical influenza infection (PICFlu), and a CDC sponsored study investigating the effectiveness of the influenza vaccine on preventing critical illness in pediatrics. Many of these studies are coordinated in association with a national organization of large academic PICUs across the U.S. and Canada called the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI).

A renowned expert in the field of pediatric critical care, Dr. Schwarz has written a book on pediatric intensive care, “Blueprints Pediatric ICU,” as well as several national journal articles on pediatric critical care topics including pediatric septic shock and severe acute asthma.

Dr. Schwarz is board certified in pediatrics and pediatric critical care. Prior to joining CHOC, Dr. Schwarz attended medical school at Stanford University School of Medicine in California. He completed his pediatric internship and residency training at Stanford University Hospital and performed his pediatric critical care fellowship at Harbor-UCLA Medical Center, CHOC and King Drew Medical Center.